Dosage: 1 to 2 co one to two doses per day
A combination of gliclazide and metformin provides good glycemic control and improves lipid levels with a better tolerability profile.
The European Society for the Management of Type 2 Diabetes recommends using oral antidiabetic agents with a cardioprotective effect; thus, the gliclazide/metformin combination has an advantage over other sulfonylurea/metformin combinations because gliclazide prevents or delays the development of vasculopathies associated with diabetes.
Reviews
There are no reviews yet.